Navigation Links
Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
Date:11/10/2008

een approved in Europe for over 50 years as safe and efficacious treatments for PSVT.

Duska is in the process of modifying the proposed design of the Phase 3 clinical trial in accordance with the FDA's comments and plans to submit a revised protocol to the FDA for Special Protocol Assessment procedure approval. Duska intends to initiate a single, prospective, double-blind, placebo-controlled and randomized trial in patients presenting to the emergency room with PSVT to demonstrate ATPace's clinical safety and efficacy. Upon successful completion of the trial, Duska intends to file a New Drug Application under section 505(b)(2).

"We chose DSM after a thorough analysis of their ability to manufacture ATPace according to our specifications and timeline, as well as meet all of the FDA's requirements of a commercial drug manufacturer," stated Amir Pelleg, PhD, Duska's President and Chief Scientific Officer. "We believe that DSM has an excellent working relationship with the FDA, experience with injectable drug products, and a superior reputation in sterile manufacturing," he added.

"We are delighted to be supporting Duska Therapeutics in bringing this important potential new therapy to market," said Hans Engels, President and Business Unit Director for DSM Pharmaceuticals, Inc. "Through our collaboration, we have experienced first-hand, Duska's commitment to excellence in serving a market with the need for improved treatments."

"We are excited to add Duska to our customer base and look forward to the anticipated launch of this key product, as well as the potential future growth with Duska," remarked Laura Parks, Senior Vice President, Marketing & Sales for DSM.

About Duska Therapeutics, Inc.

Duska Therapeutics, Inc., (Duska) is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical r
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program
2. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
3. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
4. Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM)
5. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
6. Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
7. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
8. Cornerstone Therapeutics Announces New Board of Directors
9. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
10. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
11. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... e-Spirit ... version 5.2 of the FirstSpirit Content Management System with new capabilities and enhancements ... version of FirstSpirit, companies will be well on their way to achieving digital ...
(Date:9/1/2015)... Boston, MA (PRWEB) , ... September 01, 2015 , ... ... the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of ... has the same mission – to raise awareness of the FSH Society and further ...
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER TOLEDO has announced ... with GMP requirements“ , featuring Ed Szczesny (Quality Assurance, Rhodes Pharmaceuticals) as guest ... (15:00 GMT). , Calibration, qualification, and the appropriate level of routine testing ...
(Date:9/1/2015)... ... September 01, 2015 , ... CanAm Enterprises ... have received permanent green cards (I-829 petition approval) from the USCIS through an ... the final step of the EB-5 visa process for immigrant investors to become ...
(Date:9/1/2015)... ... 2015 , ... Situations requiring fast, easy-to-understand business and personal ... time for everyone involved. These occasions highlight the value of a professional translation ... has real people available to handle any translation assignment at any time of ...
Breaking Medicine News(10 mins):Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3
... by MedPlus Centergy(TM) Solutions, will Connect Physicians, Hospitals and ... Health Outcomes , , WASHINGTON, and MADISON, N.J., ... DHCF, the District,s Medicaid agency, announced the selection of ... Incorporated (NYSE: DGX ), to implement the ...
... Interoperability Solution Expands Integrations to Address Radiology Connectivity: ... RIS, McKesson, PowerScribe and Visage Imaging , ... workflow management pioneer Compressus, Inc., today introduced the ... digital imaging and data management systems software solutions. ...
... Results of Phase III clinical studies highlight benefits of ... , NUTLEY, N.J., June 4 Roche today ... the extensive multi-national ACTEMRA(R) (tocilizumab) clinical development program will ... European League Against Rheumatism (EULAR), which will take place ...
... risk while ensuring accurate payments and compliance with Medicare standards , ... have ever wondered how to integrate Medicare Risk Adjustment with their ... latest release from Storan Technologies Inc. (STI). ... Merlin Medicare Risk Adjustment 6.0 (TM), a Web-based software solution ...
... 4 Late on Sunday, May 31st, Air France Flight 447, ... the radar during a lightning storm. With 228 people on board, ... when an American Airlines jetliner crashed in New York City, killing ... the accident, a long nightmare of grief is just beginning. ...
... , Revive Health supplements provide natural relief for pain, strengthening ... Utah, June 4 More and more research is showing ... helped simply by boosting the health of the cellular immune ... the body,s ability to absorb essential nutrients and water. This ...
Cached Medicine News:Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 2Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 3Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 4Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 2Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 3Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 4Health News:ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress 2Health News:ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress 3Health News:ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress 4Health News:St. Louis Firm Brings Medicare Risk Adjustment to iPhone 2Health News:The Tragedy of Air France Flight 447: Crash Expert Reveals Nightmare Families Are Going Through 2Health News:Breakthrough Nanotechnology Delivers Safe, Nutrition-Packed Cellular Hydration 2Health News:Breakthrough Nanotechnology Delivers Safe, Nutrition-Packed Cellular Hydration 3
(Date:9/1/2015)... , Sept. 1, 2015   Millstone Medical Outsourcing ... square feet in Olive Branch, MS. ... Branch facility has added the capacity required to ... "This expansion gives us the opportunity to grow ... President of Millstone MS. "Two and a half years ago ...
(Date:9/1/2015)... 2015   Ivenix Inc. , a medical ... closed on a $42M round of equity financing ... Partners, CICA, Inc., Easterly Capital, Fidelity Biosciences, and ... This financing will support the company,s efforts to ... LLC acted as the exclusive placement agent for ...
(Date:9/1/2015)... 1. September 2015 In nur zwei ... Mitarbeitern hat die SHL Group schnell weltweit 3.000 ... rapides Wachstum auf dem Markt der ... und das Management von SHL wieder. ... ist weltweit führend in Design und Herstellung automatischer ...
Breaking Medicine Technology:Millstone Medical Outsourcing Announces Olive Branch Expansion 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro...
... preservative free lubricating and rewetting ... eyes while you're wearing soft ... free formula is ideal for ... to preservatives and for frequent ...
Saline Solution to rinse and store soft contact lenses and for heat disinfection....
Sensitive Eyes Plus Saline Solution to rinse soft contact lenses The unique, gentle, pH-balanced formula contains potassium, an ingredient found in tears....
Medicine Products: